Engineering β-lactamase zymogens for use in protease activity assays

2014 ◽  
Vol 50 (70) ◽  
pp. 10155-10157 ◽  
Author(s):  
Hajin Kim ◽  
Hyun Kyung Yoon ◽  
Tae Hyeon Yoo

In this report, we engineered β-lactamase zymogens and developed a sensitive protease assay method based on the precursor enzymes.

2016 ◽  
Vol 8 (33) ◽  
pp. 6270-6276 ◽  
Author(s):  
Dokyung Yang ◽  
Hyeon Ji Park ◽  
Tae Hyeon Yoo

A protease assay platform technology based on engineered proenzymes has been developed for diagnosis of diseases.


1998 ◽  
Vol 70 (18) ◽  
pp. 3824-3827 ◽  
Author(s):  
Douglas B. Craig ◽  
Jerome C. Y. Wong ◽  
Robert Polakowski ◽  
Norman J. Dovichi

2004 ◽  
Vol 9 (5) ◽  
pp. 398-408 ◽  
Author(s):  
Tabassum Naqvi ◽  
Anice Lim ◽  
Riaz Rouhani ◽  
Raj Singh ◽  
Richard M. Eglen

The authors describe a homogeneous, high-throughput screening (HTS) assay for measuring protease activity and detection of inhibitors. The assay comprises a cyclic β-galactosidase (β-gal) enzyme donor peptide (ED) containing a protease-selective cleavage sequence. Alone, the cyclic peptide is inactive, but when linearized following protease cleavage, ED complements with β-gal enzyme acceptor forming active β-gal enzyme. This then catalyzes the formation of either fluorescent or chemiluminescent products, with β-gal turnover providing a highly amplified signal, and thus an assay technology of high sensitivity. To demonstrate the utility of the technology, an EFC assay was developed to measure the activity of 2, caspase 3 and β-secretase. Using a cyclic ED containing the caspase 3 substrate sequence, DEVD, the EFC assay signal was linear with respect to caspase 3 concentration. The assay was very sensitive, being able to detect activity at low picogram amounts of caspase 3. For the β-secretase (BACE) EFC assay, a cyclic ED containing the Swedish mutant cleavage site of amyloid precursor protein (APP), SEVNLDAEFK, was used. In a similar fashion to the caspase 3 assay, the signal induced by BACE activity was linear with respect to enzyme concentration and was highly sensitive, being able to detect nanogram quantities of BACE. The assay was also more sensitive than a commercially available FRET-based assay of BACE activity. It is concluded that the EFC protease assay is a simple, flexible, and sensitive technology for HTS of proteases.


Author(s):  
Naxin Jiang ◽  
Nguan Soon Tan ◽  
Bow Ho ◽  
Jeak Ling Ding

1973 ◽  
Vol 30 (03) ◽  
pp. 471-479 ◽  
Author(s):  
K. W. E Denson ◽  
John Bonnar

SummaryA method for the measurement of heparin utilising the potentiating effect of heparin on the action of anti-factor Xa is described. The effect on the assay of platelet contamination of plasma, the presence of fibrinogen degradation products and low levels of anti-factor Xa have been studied. The assay method has been compared with the calcium thrombin time method and a group of obstetrical patients have been studied using both methods.


Sign in / Sign up

Export Citation Format

Share Document